Haven't used Crossbeta Biosciences yet?
Ask AI

Ask AI about Crossbeta Biosciences

Generated with AI from 11 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Jordan Watson
Reviews 1

My experience with Crossbeta Biosciences was fantastic! They have a highly skilled team that provided excellent service. The staff was friendly and responsive to my needs. I would definitely recommend their services to anyone in need.

Ken Bernard
Reviews 1

I had a decent experience with Crossbeta Biosciences. The website was easy to navigate and had all the necessary information. The company seems to be professional and reliable. However, I think they can improve their customer support as it took a while for them to respond to my inquiries.

Kent Neimann
Reviews 1

I recently worked with Crossbeta Biosciences and it was a wonderful experience. The team was extremely professional and their attention to detail was commendable. They delivered the results on time and exceeded my expectations. I would definitely work with them again.

Questions & Answers

No questions yet โ€” be the first to ask.

News & Press

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying widget on your website โ€” its a simple way to convert your visitors into customers.

Embed code

<script src="https://trustburn.com/widgets/index.js"></script>
<div class="trustburn-widget" data-trustburn-protocol="https:" data-trustburn-domain="trustburn.com" data-trustburn-widget="score" data-company-path="crossbeta-com" data-lang="en"></div>
More widgets

About Crossbeta Biosciences

Crossbeta Biosciences is a biotech company that has developed an innovative technology to generate stable oligomers for drug discovery and development in disease areas characterized by the presence of misfolded proteins, such as Alzheimerโ€™s, Parkinsonโ€™s, Huntingtonโ€™s disease and ALS. Crossbetaโ€™s unique stable oligomers maintain their biopathological properties for the screening of oligomer-specific therapeutics and for the development of biomarker and diagnostic assays.